0000950123-20-012657 Sample Contracts

INVESTORS’ RIGHTS AGREEMENT

Investors’ Rights Agreement • December 15th, 2020 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Investors’ Rights Agreement
• Filed
  December 15th, 2020
• Company
  Longboard Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of October 27, 2020, by and among Longboard Pharmaceuticals, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and, solely for purposes of Sections 1.5, 1.19, 4, 5.5 and 6, Arena Pharmaceuticals, Inc. (“ARNA”).

SERVICES AGREEMENT

Services Agreement • December 15th, 2020 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations • California

• Contract Type
  Services Agreement
• Filed
  December 15th, 2020
• Company
  Longboard Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

THIS SERVICES AGREEMENT (this “Agreement”), effective as of October 27, 2020 (the “Effective Date”) by and between Arena Pharmaceuticals, Inc., a Delaware corporation (“Arena”) and Longboard Pharmaceuticals, Inc., a Delaware corporation (“Longboard”). Longboard and Arena are referred to individually as a “Party” and collectively as the “Parties”.

LICENSE AGREEMENT

License Agreement • December 15th, 2020 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

• Contract Type
  License Agreement
• Filed
  December 15th, 2020
• Company
  Longboard Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS LICENSE AGREEMENT (the “Agreement”) is entered into as of October 27, 2020 (the “Effective Date”), by and between LONGBOARD PHARMACEUTICALS, INC., a Delaware corporation (“Licensee”), and ARENA PHARMACEUTICALS INC., a Delaware corporation (“Licensor”).

Royalty Purchase Agreement

Royalty Purchase Agreement • December 15th, 2020 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations • California

• Contract Type
  Royalty Purchase Agreement
• Filed
  December 15th, 2020
• Company
  Longboard Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

This Royalty Purchase Agreement (the “Agreement”), dated as of October 27, 2020, is by and between Arena Pharmaceuticals, Inc. (“Parent”), 356 Royalty Inc., a Delaware corporation and wholly-owned subsidiary of Parent (“356”), and Longboard Pharmaceuticals, Inc., a Delaware corporation and wholly-owned subsidiary of Parent (the “Company”). Capitalized terms used but not defined herein shall have the meaning ascribed to such terms in that certain Transaction Agreement, dated as of December 28, 2016, by and among 356, Eisai Inc. and Eisai Co., Ltd. (the “Transaction Agreement”).